Therapeutic Solutions International, Inc. engages in the provision of immune modulation for the treatment of several specific diseases. The firm is also involved in developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, traumatic brain injury, and for daily health. The company was founded on August 6, 2007 and is headquartered in Elk, ID.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company